; however, the significance of this is unclear. Therefore, to elucidate the role Myc has in the intestine after Apc loss, we have simultaneously deleted both Apc and Myc in the adult murine small intestine. Here we show that loss of Myc rescued the phenotypes of perturbed differentiation, migration, proliferation and apoptosis, which occur on deletion of Apc. Remarkably, this rescue occurred in the presence of high levels of nuclear b-catenin. Array analysis revealed that Myc is required for the majority of Wnt target gene activation following Apc loss. These data establish Myc as the critical mediator of the early stages of neoplasia following Apc loss.
We have previously used a conditional gene deletion approach to study the immediate effects of loss of Apc on differentiation, proliferation and migration in the murine small intestine 6 . These studies have shown that loss of Apc leads to unrestricted proliferation within the intestinal crypt, resulting in multiple changes, including an increase in BrdU incorporation, MCM staining and dramatically enlarged crypts at four days post Apc loss 6 . Similar analyses of Myc deficiency have shown remarkably little effect of gene deletion on intestinal proliferation and apoptosis over a five day time course 7, 8 . To examine how Myc affected the phenotypes associated with Apc loss, we intercrossed AhCre mice carrying the ROSA26 floxed stop cassette lacZ reporter showed near 100% recombination of the reporter allele, indicating retention of double-mutant Apc-, Myc-deficient crypts ( Supplementary Fig. 1a ). This highlighted that Cre-mediated deletion of both Myc and Apc was not immediately deleterious to intestinal enterocytes. To confirm that this protocol produced crypts that were both Apc-and Mycdeficient we performed immunohistochemistry for Myc and nuclear b-catenin (a downstream marker of Apc loss). To confirm co-incident Apc and Myc loss, we performed in situ hybridization for Apc and immunohistochemistry for Myc and b-catenin in serial sections and saw loss of both Apc and Myc and the appearance of nuclear b-catenin ( Supplementary Fig. 2 ). Indeed, scoring serial sections revealed combined gene loss in 88.5% (65% s.d.) of crypts (n 5 3 mice, 100 crypts scored per mouse). Finally, to show loss of Apc protein, we performed immunofluorescence for Apc ( Supplementary Fig. 3 ). Histological analysis showed that wildtype and doubly deficient crypts were morphologically indistinguishable ( Fig. 2a-c) . Gross changes associated with Apc deficiency such as the increased crypt cellularity (Fig. 2g) , perturbed differentiation ( Fig. 2d-f ) and an increased number of mitotic figures (Fig. 2h) were absent in the double mutants. To investigate further proliferative changes, we examined levels of BrdU incorporation (Fig. 3a-c) and Ki67 staining (data not shown). In both cases the double-mutant mice did not differ significantly from wild-type mice (MannWhitney U test; P 5 .0.4), and showed lower indices than Apc null tissue and a restoration of the normal proliferation zone (MannWhitney U test; P 5 0.04) (Fig. 3d-f) . We next scored the capacity of double-mutant cells to migrate along the crypt villus axis by comparing the position of BrdU positive cells at 2 and 24 h after exposure. Remarkably, unlike Apc-deficient cells, migration in the double-mutant mice was normal (Fig. 3f) . This rescue explains the presence of cells with nuclear b-catenin in the double-mutant villi (see Fig. 1f ).
Levels of nuclear b-catenin remained high in the doubly deficient intestines, providing an ideal opportunity to dissect out Mycdependent and -independent targets of the Wnt pathway. We therefore performed microarray analysis with the affymetrix MOE430_2 chip using RNA from AhCre Myc 1/1 intestines at four days after gene deletion 6 . The data were analysed using fold change, rank product 9 and SAM 10 (statistical analysis of microarrays) analysis with a false discovery rate (FDR) of no more that 5%. These analyses indicated significant changes between the three genotypes, listed in Supplementary  Tables 1-3 . Following only Apc loss, SAM analysis using a 5% FDR identified 58 genes that had previously been defined by the literature as Wnt target genes 11 (many are shown at the following website: http://www.stanford.edu/,rnusse/pathways/targets.html). Similar, overlapping gene sets were identified by fold change or rank product analysis (46 known Wnt target genes were increased by 2-fold or greater; 51 were identified according to rank product analysis). We next examined the expression of these genes in the Apc fl/fl Myc fl/fl double mutants and found that additional deficiency of Myc blocked the upregulation of the majority of these Wnt target genes (see Supplementary Table 4) . Sixty-two per cent of genes (36/58) identified by SAM analysis were significantly downregulated in the double knockouts; 27/46 (59%) were downregulated as assessed by fold change; and 32/51 (62%) were significantly downregulated according to rank product analysis. These genes include axin2, tcf1, tiam1 (ref.
12) and Sox17, and thus are identified as Myc-dependent (Supplementary Table 4 ). In contrast, a smaller percentage of these genes (including CD44, Cyclin D2 and Troy) were unaffected by the additional loss of Myc, reflecting Myc independence. We confirmed a subset of these changes by real time quantitative reverse transcriptase (qRT)-PCR ( Supplementary Fig. 4 ).
Thus, we define, in an in vivo setting, a subset of Wnt target genes for which Myc is essential. This subset of target genes is critical in imposing the Apc-deficient phenotype. For example, we have previously shown that perturbation of the EphB/EphrinB system, following Apc loss, results in mislocalization of Paneth cells 6, 13 . In the double mutants, these Tcf4 target genes were no longer transcriptionally elevated, and consistent with this, we observed normal localization of the Paneth cells in the double mutants ( Fig. 3g-j) . Critically, the Wnt target genes that we identify as Myc-independent are insufficient to impose the phenotypes associated with Apc deficiency.
In the double mutants, a number of genes associated with DNA and RNA replication were no longer transcriptionally upregulated (for example, DNA polymerase e, MCM2, MCM7, Brf1, RNA polymerase I subunits, RNA polymerase II, eif4c, and the rRNA genes (RpS11-13, S18 and L13) . Our data are therefore consistent with numerous reports of Myc driving transcription of genes associated with proliferation 14 ; however, we cannot rule out the possibility that these changes simply reflect the reduced proliferation that we observe.
Previous studies have postulated that Myc may facilitate proliferation through repression of p21 (ref. 5) . This is unlikely to be a direct effect within normal intestinal crypts because there is no induction of p21 and no obvious G1 arrest when Myc is deleted 7, 8 . However, repression of p21 by Myc was demonstrated in colorectal cancer cell lines mutant for Apc, raising the possibility that repression of p21 may only be important in the context of activated Wnt signalling. To address this, we performed immunohistochemistry for p21 (Fig. 3k-m) and found p21 to be upregulated within the crypts of double-mutant Apc fl/fl Myc fl/fl mice. This argues that the loss of the crypt progenitor-cell-like phenotype in double-mutant mice may be partially due to the inability to repress p21.
Previous reports have suggested that Myc can integrate and balance different survival signals. In certain contexts, Myc expression can lead to proliferation, whereas in other contexts, activation of Myc drives apoptosis 15, 16 . Given the failure to see increased proliferation in the double mutants, we next investigated levels of apoptosis in the Supplementary Fig. 5a ), showing Myc dependency for both apoptosis and proliferation, following activation of the Wnt pathway. To investigate further the link between proliferation and death, we pulse-labelled with BrdU and followed the fate of labelled cells. Within wild-type crypts, there was a 43% increase in the number of labelled cells (as a consequence of division) between 2 and 24 h (Supplementary Fig. 5b ). No such increase was observed in the AhCre 1 Apc fl/fl Myc 1/1 mice, implying that BrdUpositive cells were being deleted (Fig. 4b ). This interpretation is further supported by the observation that the mitotic index was not elevated in the Cre occurring in either the G2 or M phases 17 . In accordance with this, many of the apoptotic figures observed were large-a phenomenon previously interpreted to reflect death of 4n cells at a G2/M checkpoint 17 . This is also consistent with reports that Myc upregulation drives cells precociously into S phase 18 Fig. 6 ).
We have previously shown that single deficiency of Myc leads to reduced biosynthetic activity and strong selection against Myc-deficient stem cells 8 . We hypothesize that, in the double mutants, surrounding wild-type stem cells outcompete the double-null cells and repopulate the crypts, much as we have seen for other alleles deleted using this strategy 22, 23 . In conclusion, we show that the dramatic changes conferred by Apc deficiency are entirely dependent on functional Myc. Furthermore, given that Myc is required for the persistence of Apcdeficient cells, these data show that Myc is absolutely required for the cellular and molecular changes that occur following Apc loss in the murine small intestine.
METHODS
Mouse colonies. All experiments were performed under the UK Home Office guidelines. Outbred male mice from 6-12 weeks of age were used, and they were segregating for the C57BLJ and S129 genomes. The alleles used were as follows: Apc ) for 3 days and harvested 4 days after the first injection. At this time point, mice were killed and the small intestine removed and flushed with water. Intestines were dissected and analyses for apoptosis, mitosis and S-phase labelling were performed on the proximal intestine, as described in Supplementary Methods. In situ hybridization, immunohistochemistry and immunofluorescence were performed as previously described 9, 11 . Detailed protocols are given in the Supplementary Methods. To determine the pattern of recombination at the ROSA26R reporter locus, intestinal whole-mounts were prepared, fixed and exposed to X-gal substrate using a method previously reported 8, 23 . For microarray analysis, RNA was extracted from 3 cm of the small intestine that was located 7 cm from the stomach. For details of RNA extraction, microarray analysis and real time qRT-PCR analysis of targets see Supplementary Methods.
